Literature DB >> 11340233

Hypertensive caudate hemorrhage prognostic predictor, outcome, and role of external ventricular drainage.

P C Liliang1, C L Liang, C H Lu, H W Chang, C H Cheng, T C Lee, H J Chen.   

Abstract

BACKGROUND AND
PURPOSE: The purpose of the present study was to analyze the outcome and outcome predictors of caudate hemorrhage and role of external ventricular drainage in acute hydrocephalus.
METHODS: Clinical data from 36 consecutive patients with hypertensive caudate hemorrhage was used in the present study. Age, gender, volume of parenchymal hematoma, hematoma in the internal capsule, initial Glasgow Coma Scale (GCS), hydrocephalus, severity of intraventricular hemorrhage, and hemorrhagic dilatation of the fourth ventricle were analyzed for effect on outcome. Effect of external ventricle drainage for hydrocephalus was evaluated by comparing preoperative and postoperative GCS scores.
RESULTS: By univariate analyses, poor outcome was associated with a poor initial GCS score (P=0.016), hydrocephalus (P<0.001), intraventricular hemorrhage severity (P<0.01), and hemorrhagic dilatation of the fourth ventricle (P=0.02). By multivariate analysis, stepwise logistic regression revealed that hydrocephalus was the only independent prognostic factor for poor outcome (P<0.001). Postoperative 48-hour GCS score was better than the preoperative score by use of paired-sample t test (P<0.001).
CONCLUSIONS: Hydrocephalus is the most important predictor of poor outcome. External ventricular drainage response for hydrocephalus was good in the present study, whereas an early decision should be made regarding preoperative neurological condition.

Entities:  

Mesh:

Year:  2001        PMID: 11340233     DOI: 10.1161/01.str.32.5.1195

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  11 in total

1.  Hydrocephalus in ICH: what do we really know?

Authors:  Allyson R Zazulia
Journal:  Neurocrit Care       Date:  2008       Impact factor: 3.210

2.  Coiling and neuroendoscopy: a new perspective in the treatment of intraventricular haemorrhages due to bleeding aneurysms.

Authors:  P Longatti; A Fiorindi; F Di Paola; S Curtolo; L Basaldella; A Martinuzzi
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-07-11       Impact factor: 10.154

3.  Caudate haemorrhage caused by pseudoaneurysm of accessory middle cerebral artery.

Authors:  Shinichiro Teramoto; Joji Tokugawa; Yasuaki Nakao; Takuji Yamamoto
Journal:  BMJ Case Rep       Date:  2015-12-30

4.  Acute treatment of hypertensive intracerebral hemorrhage.

Authors:  Thomas Mirsen
Journal:  Curr Treat Options Neurol       Date:  2010-11       Impact factor: 3.598

5.  Lumbar drainage for communicating hydrocephalus after ICH with ventricular hemorrhage.

Authors:  Hagen B Huttner; Stefan Schwab; Jürgen Bardutzky
Journal:  Neurocrit Care       Date:  2006       Impact factor: 3.210

6.  Current treatment options for intracerebral hemorrhage.

Authors:  Fred Rincon; Stephan A Mayer
Journal:  Curr Treat Options Cardiovasc Med       Date:  2008-06

7.  Presentation of intracerebral haemorrhage in a community.

Authors:  D B Zahuranec; N R Gonzales; D L Brown; L D Lisabeth; P J Longwell; S V Eden; M A Smith; N M Garcia; J T Hoff; L B Morgenstern
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-03       Impact factor: 10.154

Review 8.  [Critical care management of intracerebral hemorrhage].

Authors:  V Huge
Journal:  Med Klin Intensivmed Notfmed       Date:  2016-05-24       Impact factor: 0.840

Review 9.  Clinical review: Critical care management of spontaneous intracerebral hemorrhage.

Authors:  Fred Rincon; Stephan A Mayer
Journal:  Crit Care       Date:  2008-12-10       Impact factor: 9.097

10.  MRI-based analysis of intracerebral hemorrhage in mice reveals relationship between hematoma expansion and the severity of symptoms.

Authors:  Hideaki Matsushita; Masanori Hijioka; Akinori Hisatsune; Yoichiro Isohama; Shigeto Iwamoto; Hiroaki Terasawa; Hiroshi Katsuki
Journal:  PLoS One       Date:  2013-07-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.